🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess the safety and efficacy of pemetrexe...
Status
Completed
Location
Peking Union Medical College Hospital ( Site 0108)
Start Date
2019-11-05
Trial ID
NCT04716933
Treatments Being Tested
This is a study of pembrolizumab (MK-3475) with or without lenvatinib (E708...
Status
Completed
Location
California Cancer Associates for Research & Excellence ( Site 0025)
Start Date
2020-02-05
Trial ID
NCT04199104
Treatments Being Tested
This is a study of pembrolizumab (MK-3475) with or without lenvatinib (E708...
Status
Completed
Location
Anhui Cancer Hospital-Radiology Department ( Site 3333)
Start Date
2020-10-30
Trial ID
NCT05523323
Treatments Being Tested
The purpose of this study is to compare the overall survival of patients re...
Status
Completed
Location
Donald W. Hill, M.D., F.A.C.P.
Start Date
2011-11
Trial ID
NCT01529112
Treatments Being Tested
The primary purpose of this study is to compare the progression-free surviv...
Status
Completed
Location
1002 Eisai Trial Site
Start Date
2017-01-11
Trial ID
NCT02966093
Treatments Being Tested
This is a multicenter, randomized, double-blind study being conducted as a ...
Status
Completed
Location
Facility#1
Start Date
2017-06-08
Trial ID
NCT02702388
Treatments Being Tested
This is a multicenter, randomized, double-blind, placebo-controlled Phase 3...
Status
Completed
Location
Facility 1
Start Date
2011-03-17
Trial ID
NCT01321554
Treatments Being Tested
The purpose of this study is to assess the safety and efficacy of pemetrexe...
Status
Completed
Location
El Camino Hospital Cancer Center ( Site 0529)
Start Date
2019-03-25
Trial ID
NCT03829319
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of lenvati...
Status
Completed
Location
Arizona Oncology Associates PC- HOPE ( Site 0770)
Start Date
2020-05-22
Trial ID
NCT04246177
Treatments Being Tested
This is a double-blind (vis-a-vis lenvatinib), randomized, placebo-controll...
Status
Completed
Location
Charles River
Start Date
2010-12
Trial ID
NCT01525394
Treatments Being Tested